Literature DB >> 6192752

A comparison of two steroid receptor assays in breast cancer: dextran coated charcoal and isoelectric focusing.

M Fernö, A Borg, A Norgren.   

Abstract

The multiple point dextran coated charcoal technique with Scatchard analysis (DCC) and isoelectric focusing on polyacrylamide gels (IF) were compared with regard to steroid receptor recovery, amount of tissue necessary, and expenses of assay. Quantitative correlations showed that when using DCC as compared to IF, estradiol receptor (ER) recovery increased two and progesterone receptor (PgR) recovery increased four times. In spite of lower recovery, IF may be a good alternative to DCC for routine ER assay since a small amount of tissue is required and the IF assay is easy to evaluate. The two assays were approximately equal in expense.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192752

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect.

Authors:  L E Rutqvist; B Cedermark; U Glas; H Johansson; B Nordenskjöld; L Skoog; A Somell; T Theve; S Friberg; J Askergren
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

2.  Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation.

Authors:  M Fernö; B Baldetorp; P O Bendahl; A Borg; S B Ewers; H Olsson; S Rydén; H Sigurdsson; D Killander
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

3.  Prognostic implication of estrogen receptor content in breast cancer.

Authors:  H O Adami; S Graffman; A Lindgren; J Sällström
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients.

Authors:  H Jernström; J Frenander; M Fernö; H Olsson
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

5.  Classical oestrogen receptor is not detectable in pancreatic adenocarcinoma.

Authors:  O M Taylor; J Teasdale; P N Cowen; M J McMahon; E A Benson
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

6.  Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Authors:  A Borg; H Sigurdsson; G M Clark; M Fernö; S A Fuqua; H Olsson; D Killander; W L McGurie
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.